Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Blood Cancer Journal
|
January 12, 2013
Molecular pathways of early CD105-positive erythroid cells as compared with CD34-positive common precursor cells by flow cytometric cell-sorting and gene expression profiling
S Machherndl-Spandl, S Suessner, M Danzer, et al.
Blood Cancer Journal
|
February 12, 2013
Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules
E Leich, S Weißbach, H-U Klein, et al.
Leukemia
|
November 14, 2013
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T Haferlach, Y Nagata, V Grossmann, et al.
Leukemia
|
June 18, 2011
The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories
A Kohlmann, H-U Klein, S Weissmann, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Blood Cancer Journal
|
January 12, 2013
Molecular pathways of early CD105-positive erythroid cells as compared with CD34-positive common precursor cells by flow cytometric cell-sorting and gene expression profiling
S Machherndl-Spandl, S Suessner, M Danzer, et al.
Blood Cancer Journal
|
February 12, 2013
Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules
E Leich, S Weißbach, H-U Klein, et al.
Leukemia
|
November 14, 2013
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T Haferlach, Y Nagata, V Grossmann, et al.
Leukemia
|
June 18, 2011
The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories
A Kohlmann, H-U Klein, S Weissmann, et al.
Page
of 7